Carrie B Hruska1, Amy Lynn Conners2, Celine M Vachon3, Michael K O'Connor2, Lynne T Shuster4, Adam C Bartley3, Deborah J Rhodes4. 1. Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905. Electronic address: hruska.carrie@mayo.edu. 2. Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905. 3. Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. 4. Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Abstract
RATIONALE AND OBJECTIVES: The level of Tc-99m sestamibi uptake within normal fibroglandular tissue on molecular breast imaging (MBI), termed background parenchymal uptake (BPU), has been anecdotally observed to fluctuate with menstrual cycle. Our objective was to assess the impact of menstrual cycle phase on BPU appearance. MATERIALS AND METHODS: Premenopausal volunteers who reported regular menstrual cycles and no exogenous hormone use were recruited to undergo serial MBI examinations during the follicular and luteal phase. A study radiologist, blinded to cycle phase, categorized BPU as photopenic, minimal mild, moderate, or marked. Change in BPU with cycle phase was determined, as well as correlations of BPU with mammographic density and hormone levels. RESULTS: In 42 analyzable participants, high BPU (moderate or marked) was observed more often in luteal phase compared to follicular (P = .016). BPU did not change with phase in 30 of 42 participants (71%) and increased in the luteal phase compared to follicular in 12 (29%). High BPU was more frequent in dense breasts compared to nondense breasts at both the luteal (58% [15 of 26] vs. 13% [2 of 16], P = .004) and follicular phases (35% [9 of 26] vs. 6% [1 of 16], P = .061). Spearman correlation coefficients did not show any correlation of BPU with hormone levels measured at either cycle phase and suggested a weak correlation between change in BPU and changes in estrone and estradiol between phases. CONCLUSIONS: We observed variable effects of menstrual cycle on BPU among our cohort of premenopausal women; however, when high BPU was observed, it was most frequently seen during the luteal phase compared to follicular phase and in women with dense breasts compared to nondense breasts.
RATIONALE AND OBJECTIVES: The level of Tc-99msestamibi uptake within normal fibroglandular tissue on molecular breast imaging (MBI), termed background parenchymal uptake (BPU), has been anecdotally observed to fluctuate with menstrual cycle. Our objective was to assess the impact of menstrual cycle phase on BPU appearance. MATERIALS AND METHODS: Premenopausal volunteers who reported regular menstrual cycles and no exogenous hormone use were recruited to undergo serial MBI examinations during the follicular and luteal phase. A study radiologist, blinded to cycle phase, categorized BPU as photopenic, minimal mild, moderate, or marked. Change in BPU with cycle phase was determined, as well as correlations of BPU with mammographic density and hormone levels. RESULTS: In 42 analyzable participants, high BPU (moderate or marked) was observed more often in luteal phase compared to follicular (P = .016). BPU did not change with phase in 30 of 42 participants (71%) and increased in the luteal phase compared to follicular in 12 (29%). High BPU was more frequent in dense breasts compared to nondense breasts at both the luteal (58% [15 of 26] vs. 13% [2 of 16], P = .004) and follicular phases (35% [9 of 26] vs. 6% [1 of 16], P = .061). Spearman correlation coefficients did not show any correlation of BPU with hormone levels measured at either cycle phase and suggested a weak correlation between change in BPU and changes in estrone and estradiol between phases. CONCLUSIONS: We observed variable effects of menstrual cycle on BPU among our cohort of premenopausal women; however, when high BPU was observed, it was most frequently seen during the luteal phase compared to follicular phase and in women with dense breasts compared to nondense breasts.
Authors: Amy Lynn Conners; Carrie B Hruska; Cindy L Tortorelli; Robert W Maxwell; Deborah J Rhodes; Judy C Boughey; Wendie A Berg Journal: Eur J Nucl Med Mol Imaging Date: 2012-06 Impact factor: 9.236
Authors: Hoon-Hee Park; Ji Yun Shin; Ju Young Lee; Gye Hwan Jin; Hyun Soo Kim; Kwang Yul Lyu; Tae Soo Lee Journal: Conf Proc IEEE Eng Med Biol Soc Date: 2013
Authors: Lauren R Rechtman; Megan J Lenihan; Jennifer H Lieberman; Christine B Teal; Jessica Torrente; Jocelyn A Rapelyea; Rachel F Brem Journal: AJR Am J Roentgenol Date: 2014-02 Impact factor: 3.959
Authors: S A Khan; A Sachdeva; S Naim; M M Meguid; W Marx; H Simon; J D Halverson; P J Numann Journal: Cancer Epidemiol Biomarkers Prev Date: 1999-10 Impact factor: 4.254
Authors: Carrie B Hruska; Deborah J Rhodes; Amy Lynn Conners; Katie N Jones; Rickey E Carter; Ravi K Lingineni; Celine M Vachon Journal: AJR Am J Roentgenol Date: 2015-03 Impact factor: 3.959
Authors: Deborah J Rhodes; Carrie B Hruska; Amy Lynn Conners; Cindy L Tortorelli; Robert W Maxwell; Katie N Jones; Alicia Y Toledano; Michael K O'Connor Journal: AJR Am J Roentgenol Date: 2015-02 Impact factor: 3.959
Authors: Amy Lynn Conners; Robert W Maxwell; Cindy L Tortorelli; Carrie B Hruska; Deborah J Rhodes; Judy C Boughey; Wendie A Berg Journal: AJR Am J Roentgenol Date: 2012-12 Impact factor: 3.959
Authors: Matthew F Covington; Ephraim E Parent; Elizabeth H Dibble; Gaiane M Rauch; Amy M Fowler Journal: J Nucl Med Date: 2021-12-09 Impact factor: 11.082
Authors: Carrie B Hruska; Jennifer R Geske; Tiffinee N Swanson; Alyssa N Mammel; David S Lake; Armando Manduca; Amy Lynn Conners; Dana H Whaley; Christopher G Scott; Rickey E Carter; Deborah J Rhodes; Michael K O'Connor; Celine M Vachon Journal: Breast Cancer Res Date: 2018-06-05 Impact factor: 6.466
Authors: Carrie B Hruska; Katie N Hunt; Amy Lynn Conners; Jennifer R Geske; Kathleen R Brandt; Amy C Degnim; Celine M Vachon; Michael K O'Connor; Deborah J Rhodes Journal: Breast Cancer Res Date: 2019-03-08 Impact factor: 6.466
Authors: Carrie B Hruska; Christopher G Scott; Amy Lynn Conners; Dana H Whaley; Deborah J Rhodes; Rickey E Carter; Michael K O'Connor; Katie N Hunt; Kathleen R Brandt; Celine M Vachon Journal: Breast Cancer Res Date: 2016-04-26 Impact factor: 6.466